Report Detail
Global Dystrophin Market Insights, Forecast to 2025
- RnM2888614 |
- 12 February, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global Dystrophin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dystrophin market based on company, product type, end user and key regions.
This report studies the global market size of Dystrophin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dystrophin in these regions.
This research report categorizes the global Dystrophin market by top players/brands, region, type and end user. This report also studies the global Dystrophin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Market size by Product
DS-5141
Biostrophin
BMBD-001
NS-065
Others
Market size by End User
Genetic Disorders
Musculoskeletal Disorders
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dystrophin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dystrophin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dystrophin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dystrophin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dystrophin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dystrophin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dystrophin Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dystrophin Market Size Growth Rate by Product
- 1.4.2 DS-5141
- 1.4.3 Biostrophin
- 1.4.4 BMBD-001
- 1.4.5 NS-065
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Dystrophin Market Size Growth Rate by End User
- 1.5.2 Genetic Disorders
- 1.5.3 Musculoskeletal Disorders
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dystrophin Market Size
- 2.1.1 Global Dystrophin Revenue 2014-2025
- 2.1.2 Global Dystrophin Sales 2014-2025
- 2.2 Dystrophin Growth Rate by Regions
- 2.2.1 Global Dystrophin Sales by Regions
- 2.2.2 Global Dystrophin Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dystrophin Sales by Manufacturers
- 3.1.1 Dystrophin Sales by Manufacturers
- 3.1.2 Dystrophin Sales Market Share by Manufacturers
- 3.1.3 Global Dystrophin Market Concentration Ratio (CR5 and HHI)
- 3.2 Dystrophin Revenue by Manufacturers
- 3.2.1 Dystrophin Revenue by Manufacturers (2014-2019)
- 3.2.2 Dystrophin Revenue Share by Manufacturers (2014-2019)
- 3.3 Dystrophin Price by Manufacturers
- 3.4 Dystrophin Manufacturing Base Distribution, Product Types
- 3.4.1 Dystrophin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dystrophin Product Type
- 3.4.3 Date of International Manufacturers Enter into Dystrophin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dystrophin Sales by Product
- 4.2 Global Dystrophin Revenue by Product
- 4.3 Dystrophin Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dystrophin Breakdown Data by End User
6 North America
- 6.1 North America Dystrophin by Countries
- 6.1.1 North America Dystrophin Sales by Countries
- 6.1.2 North America Dystrophin Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dystrophin by Product
- 6.3 North America Dystrophin by End User
7 Europe
- 7.1 Europe Dystrophin by Countries
- 7.1.1 Europe Dystrophin Sales by Countries
- 7.1.2 Europe Dystrophin Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dystrophin by Product
- 7.3 Europe Dystrophin by End User
8 Asia Pacific
- 8.1 Asia Pacific Dystrophin by Countries
- 8.1.1 Asia Pacific Dystrophin Sales by Countries
- 8.1.2 Asia Pacific Dystrophin Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dystrophin by Product
- 8.3 Asia Pacific Dystrophin by End User
9 Central & South America
- 9.1 Central & South America Dystrophin by Countries
- 9.1.1 Central & South America Dystrophin Sales by Countries
- 9.1.2 Central & South America Dystrophin Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dystrophin by Product
- 9.3 Central & South America Dystrophin by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dystrophin by Countries
- 10.1.1 Middle East and Africa Dystrophin Sales by Countries
- 10.1.2 Middle East and Africa Dystrophin Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dystrophin by Product
- 10.3 Middle East and Africa Dystrophin by End User
11 Company Profiles
- 11.1 Asklepios BioPharmaceutical Inc
- 11.1.1 Asklepios BioPharmaceutical Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Asklepios BioPharmaceutical Inc Dystrophin Products Offered
- 11.1.5 Asklepios BioPharmaceutical Inc Recent Development
- 11.2 BioMarin Pharmaceutical Inc
- 11.2.1 BioMarin Pharmaceutical Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 BioMarin Pharmaceutical Inc Dystrophin Products Offered
- 11.2.5 BioMarin Pharmaceutical Inc Recent Development
- 11.3 Daiichi Sankyo Company Ltd
- 11.3.1 Daiichi Sankyo Company Ltd Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Daiichi Sankyo Company Ltd Dystrophin Products Offered
- 11.3.5 Daiichi Sankyo Company Ltd Recent Development
- 11.4 Editas Medicine Inc
- 11.4.1 Editas Medicine Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Editas Medicine Inc Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Editas Medicine Inc Dystrophin Products Offered
- 11.4.5 Editas Medicine Inc Recent Development
- 11.5 Genethon SA
- 11.5.1 Genethon SA Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Genethon SA Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Genethon SA Dystrophin Products Offered
- 11.5.5 Genethon SA Recent Development
- 11.6 Nippon Shinyaku Co Ltd
- 11.6.1 Nippon Shinyaku Co Ltd Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Nippon Shinyaku Co Ltd Dystrophin Products Offered
- 11.6.5 Nippon Shinyaku Co Ltd Recent Development
- 11.7 Pfizer Inc
- 11.7.1 Pfizer Inc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pfizer Inc Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pfizer Inc Dystrophin Products Offered
- 11.7.5 Pfizer Inc Recent Development
- 11.8 Sarepta Therapeutics Inc
- 11.8.1 Sarepta Therapeutics Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sarepta Therapeutics Inc Dystrophin Products Offered
- 11.8.5 Sarepta Therapeutics Inc Recent Development
- 11.9 WAVE Life Sciences Ltd
- 11.9.1 WAVE Life Sciences Ltd Company Details
- 11.9.2 Company Business Overview
- 11.9.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 WAVE Life Sciences Ltd Dystrophin Products Offered
- 11.9.5 WAVE Life Sciences Ltd Recent Development
12 Future Forecast
- 12.1 Dystrophin Market Forecast by Regions
- 12.1.1 Global Dystrophin Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dystrophin Revenue Forecast by Regions 2019-2025
- 12.2 Dystrophin Market Forecast by Product
- 12.2.1 Global Dystrophin Sales Forecast by Product 2019-2025
- 12.2.2 Global Dystrophin Revenue Forecast by Product 2019-2025
- 12.3 Dystrophin Market Forecast by End User
- 12.4 North America Dystrophin Forecast
- 12.5 Europe Dystrophin Forecast
- 12.6 Asia Pacific Dystrophin Forecast
- 12.7 Central & South America Dystrophin Forecast
- 12.8 Middle East and Africa Dystrophin Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dystrophin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dystrophin . Industry analysis & Market Report on Dystrophin is a syndicated market report, published as Global Dystrophin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dystrophin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
